Key Insights

Highlights

Treatment Research

2 treatments under study, led by No Intervention

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1
Active Not Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06255782Phase 3Active Not Recruiting

An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency

NCT06805695Recruiting

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

Showing all 2 trials

Research Network

Common Treatments

  • No Intervention1
  • Ecur5061

Active Sponsors

  • iECURE, Inc.2

Top Investigators

Related Conditions

  • Ornithine Transcarbamylase Deficiency Disease2
  • Ornithine Transcarbamylase Deficiency2
  • Urea Cycle Disorders Inborn2
  • Ornithine Carbamoyltransferase Deficiency Disorder1

Activity Timeline